Resilient Biotics, Inc.
Resilient Biotics is utilizing advanced microbiome genomics and data science for prevention and precision treatment of deadly infectious diseases.
What matters now
- 1 investornamed
1 investor on record.
The investors already on the cap table shape who leads the next round.
- 3 directorsboard
3 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 2
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
- Aug 16, 2022Form D equity offering · $3.8M (form d sold) · 5 investorsFGC Management Co., LLC via John Gage PeryamFact Form D · “Resilient Biotics, Inc. filed Form D/A: $3,837,000 sold of $4,000,000, Biotechnology”
- Dec 2, 2020Form D equity offering · $7.2M (form d sold)FGC Management Co., LLC via John Gage PeryamFact Form D · “Resilient Biotics, Inc. Form D, first filed 2020-12-15”
- FGC Management Co., LLC portfolio listing Fact fgcvc.com
- FGC Management Co., LLC form d related, John Gage Peryam (strongly supported) Inference sec.gov
- FGC Management Co., LLC form d related, John Gage Peryam (strongly supported) Inference sec.gov
Listed on 1 firm portfolio page; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.
Evidence: 1 listingeach firm's own card, as read
- Status not stated on FGC Management Co., LLC · the firm's card prints no outcome · read Sep 30, 2026 fgcvc.com“Resilient Biotics”
- Christopher Belnap Executive Officer/Director sec.gov
- Rachelle Galvin Executive Officer/Director sec.gov
- Drew Lanza Director Fact
- Eric Eason Director Fact
- John Peryam Director Fact
Every observation on this company
- Description: Sep 27, 2026 Fact Company website
- Entity type: Corporation Dec 12, 2024 Fact Form D
- Entity type: Corporation Sep 6, 2024 Fact Form D
- Form D industry group: Biotechnology Dec 12, 2024 Fact Form D
- Form D industry group: Biotechnology Sep 6, 2024 Fact Form D
- Amendment: true Dec 12, 2024 Fact Form D
- Amendment: true Sep 6, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Dec 12, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Sep 6, 2024 Fact Form D
- Incorporated: overFiveYears Dec 12, 2024 Fact Form D
- Incorporated: overFiveYears Sep 6, 2024 Fact Form D
- Jurisdiction: Delaware Dec 12, 2024 Fact Form D
- Jurisdiction: Delaware Sep 6, 2024 Fact Form D
- Amount sold (Form D): $3.9M Dec 12, 2024 Fact Form D
- Amount sold (Form D): $3.8M Sep 6, 2024 Fact Form D
- Offering amount (Form D): $4.6M Dec 12, 2024 Fact Form D
- Offering amount (Form D): $4.0M Sep 6, 2024 Fact Form D
- Exemptions: 06b Dec 12, 2024 Fact Form D
- Exemptions: 06b Sep 6, 2024 Fact Form D
- First sale: 2022-08-16 Dec 12, 2024 Fact Form D
- First sale: 2022-08-16 Sep 6, 2024 Fact Form D
- Investors (Form D): 6 Dec 12, 2024 Fact Form D
- Investors (Form D): 5 Sep 6, 2024 Fact Form D
- Minimum investment (Form D): 0 Dec 12, 2024 Fact Form D
- Minimum investment (Form D): 0 Sep 6, 2024 Fact Form D
- Securities offered: Debt, option Dec 12, 2024 Fact Form D
- Securities offered: Debt, option Sep 6, 2024 Fact Form D
- Office address: Dec 12, 2024 Fact Form D
- Office address: Sep 6, 2024 Fact Form D
- Listed on portfolio page: FGC Management Co., LLC Sep 30, 2026 Fact Firm website
- Listed on portfolio page: FGC Management Co., LLC Sep 16, 2026 Fact Firm website
- Listed on portfolio page: FGC Management Co., LLC Sep 12, 2026 Fact Firm website
- Website status: ok Sep 27, 2026 Fact Company website
- Site title: Sep 27, 2026 Fact Company website
Record history
- Form D filed2024-12-12source on record
- Form D filed2024-09-06source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.